Knockdown of the full cluster in medulloblastoma cells results in dysregulation of the PI3K/AKT/mTOR signaling axis and enhancement of genes related to apoptosis [17]; thus, the miR-183/96/182 cluster again appears as an attractive target for potential therapeutic applications in MCC. The gene discussed is MTOR; the disease is medulloblastoma.